RVMD
Revolution Medicines, Inc.Company Information
- Company Name
- Revolution Medicines, Inc.
- CIK
- CIK0001628171
- Category
- Large accelerated filer
- Ticker: Exchange
- RVMD: Nasdaq, RVMDW: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- RVMD
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-12-05
- Last sale
- 2026-06-24
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 691,868
Institutional Sentiment
- As of
- 2026-03-31
- Institutional shares owned
- 192,688,738
- Shares outstanding
- 198,098,047
- Ownership
- 97.27%
Earnings Market Reaction
- Filing date
- 2026-08-05
- Price on filing date
- —
- 1-month reaction
- 5.36%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 815 | 441 | 384 | 217 | 402 | 334 | 543 | 201 | 276 | 288 | 696 | 358 | ||||||
| Marketable Securities Current | 3,123 | 1,467 | 1,642 | 1,714 | 1,735 | 1,769 | 1,746 | 1,348 | 1,315 | 1,415 | 1,157 | 455 | ||||||
| Prepaid Expense And Other Assets Current | 90 | 60 | 49 | 46 | 39 | 32 | 38 | 30 | 34 | 26 | 25 | 11 | ||||||
| Accounts Receivable Gross Current | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 0 | ||||||
| Assets Current | 4,028 | 1,968 | 2,075 | 1,977 | 2,176 | 2,135 | 2,328 | 1,579 | 1,625 | 1,729 | 1,879 | 824 | ||||||
| Property Plant And Equipment Net | 35 | 31 | 33 | 33 | 33 | 27 | 24 | 25 | 25 | 24 | 23 | 20 | ||||||
| Operating Lease Right Of Use Asset | 128 | 130 | 132 | 134 | 114 | 116 | 118 | 74 | 75 | 76 | 77 | 53 | ||||||
| Intangible Assets Net Excluding Goodwill | 56 | 56 | 56 | 56 | 56 | 56 | 57 | 57 | 57 | 57 | 58 | 58 | ||||||
| Goodwill | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | ||||||
| Restricted Cash Noncurrent | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 2 | ||||||
| Deposits Assets Noncurrent | 42 | 35 | 24 | 17 | - | - | 12 | - | - | - | - | - | ||||||
| Other Assets Noncurrent | 15 | 14 | 15 | 15 | 31 | 13 | 2 | 10 | 8 | 4 | 7 | 11 | ||||||
| Assets | 4,323 | 2,254 | 2,355 | 2,252 | 2,430 | 2,365 | 2,558 | 1,763 | 1,808 | 1,908 | 2,062 | 984 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 88 | 81 | 65 | 75 | 57 | 48 | 54 | 24 | 29 | 32 | 62 | 30 | ||||||
| Operating Lease Liability Current | 17 | 17 | 16 | 16 | 13 | 13 | 13 | 8 | 8 | 8 | 7 | 6 | ||||||
| Contract With Customer Liability Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Liabilities Current | 354 | 290 | 290 | 246 | 185 | 159 | 164 | 111 | 105 | 94 | 144 | 86 | ||||||
| Deferred Income Tax Liabilities Net | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | ||||||
| Operating Lease Liability Noncurrent | 138 | 140 | 142 | 142 | 120 | 121 | 123 | 78 | 79 | 80 | 81 | 57 | ||||||
| Accrued Royalties Current And Noncurrent | 549 | 281 | 268 | 257 | 245 | - | 0 | - | - | - | - | - | ||||||
| Convertible Long Term Notes Payable | 487 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Other Liabilities Noncurrent | 2 | 7 | 1 | 2 | 7 | 4 | 1 | 2 | 1 | 3 | 1 | 1 | ||||||
| Liabilities | 1,717 | 754 | 723 | 655 | 564 | 287 | 293 | 197 | 190 | 183 | 236 | 147 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital Common Stock | 6,579 | 4,823 | 4,497 | 4,098 | 4,063 | 4,028 | 4,002 | 3,106 | 3,008 | 2,980 | 2,963 | 1,814 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -6 | -1 | 3 | 3 | 1 | 2 | 1 | 4 | -2 | -1 | 1 | -1 | ||||||
| Retained Earnings Accumulated Deficit | -3,967 | -3,323 | -2,869 | -2,504 | -2,199 | -1,951 | -1,738 | -1,543 | -1,387 | -1,254 | -1,138 | -976 | ||||||
| Stockholders Equity | 2,606 | 1,500 | 1,631 | 1,597 | 1,865 | 2,078 | 2,265 | 1,566 | 1,619 | 1,725 | 1,826 | 837 | ||||||
| Liabilities And Stockholders Equity | 4,323 | 2,254 | 2,355 | 2,252 | 2,430 | 2,365 | 2,558 | 1,763 | 1,808 | 1,908 | 2,062 | 984 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | 300 | ||||||
| Common Stock Shares Issued | 214 | 200 | 197 | 190 | 187 | 186 | 186 | 173 | 171 | 170 | 170 | 109 | ||||||
| Shares Outstanding | 214 | 200 | 197 | 190 | 187 | 186 | 186 | 168 | 166 | 165 | 165 | 109 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialRevolution Medicines, Inc. (RVMD) — SEC Financial Statements & Analysis
Revolution Medicines, Inc. (RVMD) is a biological products, (no diagnostic substances) company, incorporated in DE. Revolution Medicines, Inc. trades on Nasdaq as: RVMD, RVMDW. Revolution Medicines, Inc. (RVMD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05. Based on that filing, Revolution Medicines, Inc. carries a market cap of $39.50B, a P/E ratio of -22.34x, a P/B ratio of 15.15x, a P/S ratio of 10197.27x, an enterprise value of $39.16B, and an EV/EBITDA multiple of -24.14x. On profitability, it posts an operating margin of -88031.94%, a net margin of -76423.32%, a Return on Equity (ROE) of -79.09%, a Return on Assets (ROA) of -52.37%, and a Return on Invested Capital (ROIC) of -87.20%. Per share, it reports EPS of $-8.38, diluted EPS of $-8.38, free cash flow per share of $-5.84, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of 117.75% year-over-year, and EPS growth of 94.72% year-over-year. On the balance sheet, it maintains a current ratio of 11.38x, a quick ratio of 11.12x, working capital of $3.67B, a debt-to-equity ratio of 0.66x, a debt ratio of 0.4, an interest coverage ratio of -27.42x, free cash flow of $-1.23B (TTM), and net debt of $-332.86M. Figures sourced from SEC EDGAR.
- Market Cap
- $39.50B
- P/E TTM
- -22.34x
- EPS TTM
- $-8.38
- P/B TTM
- 15.15x
- ROE TTM
- -79.09%
- ROA TTM
- -52.37%
- Debt To Equity
- 0.66x
- Free Cash Flow TTM
- $-1.23B
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Revolution Medicines, Inc. in?
Revolution Medicines, Inc. (RVMD) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does RVMD trade on?
Revolution Medicines, Inc. (RVMD) trades on the Nasdaq.
Where is Revolution Medicines, Inc. incorporated?
Revolution Medicines, Inc. is incorporated in DE.
When was Revolution Medicines, Inc. (RVMD)'s most recent SEC filing?
Revolution Medicines, Inc. (RVMD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-05.
What is RVMD's market cap?
Revolution Medicines, Inc. (RVMD) has a market capitalization of $39.50B as of 2026-06-30.
What is RVMD's EPS (earnings per share)?
Revolution Medicines, Inc. (RVMD)'s trailing twelve month EPS is $-8.38 as of 2026-06-30.
What is RVMD's ROE (return on equity)?
Revolution Medicines, Inc. (RVMD)'s trailing twelve month Return on Equity (ROE) is -79.09% as of 2026-06-30.
What is RVMD's ROA (return on assets)?
Revolution Medicines, Inc. (RVMD)'s trailing twelve month Return on Assets (ROA) is -52.37% as of 2026-06-30.
What is RVMD's ROIC (return on invested capital)?
Revolution Medicines, Inc. (RVMD)'s trailing twelve month Return on Invested Capital (ROIC) is -87.20% as of 2026-06-30.
What is RVMD's EV/EBITDA?
Revolution Medicines, Inc. (RVMD)'s trailing twelve month EV/EBITDA is -24.14x as of 2026-06-30.